New Augmentation Strategies in OCD
The Carlat Psychiatry Report, Volume 17, Number 6&7, June 2019
Michael Posternak, MD.
Psychiatrist in private practice, Boston, MA.
Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Two medications show promise in OCD, and their mechanisms are novel: one glutamatergic, one dopaminergic.